Afatinib Achieved Remarkable Disease Control in a Chinese Patient With Lung Adenocarcinoma Harboring Rare EGFR Exon 18–25 Kinase Domain Duplication

No abstract available
Source: American Journal of Therapeutics - Category: Drugs & Pharmacology Tags: Letters to the Editor Source Type: research